View in EDS

Synthesis of antiplasmodial 2-aminothieno[3,2-d]pyrimidin-4(3H)-one analogues using the scaffold hopping strategy.

Saved in:
Bibliographic Details
Title: Synthesis of antiplasmodial 2-aminothieno[3,2-d]pyrimidin-4(3H)-one analogues using the scaffold hopping strategy.
Authors: Mustière R; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, Marseille, France., Lagardère P; Institut des Biomolécules Max Mousseron, UMR 5247, CNRS, Université de Montpellier, ENSCM, UFR des Sciences Pharmaceutiques et Biologiques, Montpellier, France., Hutter S; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France., Dell'Orco V; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, Marseille, France., Amanzougaghene N; Centre d'Immunologie et des Maladies Infectieuses (CIMI), INSERM, CNRS, Sorbonne Université, Paris, France., Tajeri S; Centre d'Immunologie et des Maladies Infectieuses (CIMI), INSERM, CNRS, Sorbonne Université, Paris, France., Franetich JF; Centre d'Immunologie et des Maladies Infectieuses (CIMI), INSERM, CNRS, Sorbonne Université, Paris, France., Corvaisier S; Normandie Univ, Unicaen, CERMN, Caen, France., Since M; Normandie Univ, Unicaen, CERMN, Caen, France., Malzert-Fréon A; Normandie Univ, Unicaen, CERMN, Caen, France., Masurier N; Institut des Biomolécules Max Mousseron, UMR 5247, CNRS, Université de Montpellier, ENSCM, UFR des Sciences Pharmaceutiques et Biologiques, Montpellier, France., Lisowski V; Institut des Biomolécules Max Mousseron, UMR 5247, CNRS, Université de Montpellier, ENSCM, UFR des Sciences Pharmaceutiques et Biologiques, Montpellier, France., Verhaeghe P; CHU de Nîmes, Service de pharmacie, Nimes, France; LCC-CNRS, Université de Toulouse, CNRS UPR 8241, UPS, Toulouse, France., Mazier D; Centre d'Immunologie et des Maladies Infectieuses (CIMI), INSERM, CNRS, Sorbonne Université, Paris, France., Azas N; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France., Vanelle P; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, Marseille, France; Service Central de la Qualité et de l'Information Pharmaceutiques, APHM, Hôpital Conception, Marseille, France., Primas N; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, Marseille, France; Service Central de la Qualité et de l'Information Pharmaceutiques, APHM, Hôpital Conception, Marseille, France. Electronic address: nicolas.primas@univ-amu.fr.
Source: European journal of medicinal chemistry [Eur J Med Chem] 2022 Nov 05; Vol. 241, pp. 114619. Date of Electronic Publication: 2022 Jul 20.
Publication Type: Journal Article
Journal Info: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3254 (Electronic) Linking ISSN: 02235234 NLM ISO Abbreviation: Eur J Med Chem Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35872545
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Synthesis of antiplasmodial 2-aminothieno[3,2-d]pyrimidin-4(3H)-one analogues using the scaffold hopping strategy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mustière+R%22">Mustière R</searchLink>; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Lagardère+P%22">Lagardère P</searchLink>; Institut des Biomolécules Max Mousseron, UMR 5247, CNRS, Université de Montpellier, ENSCM, UFR des Sciences Pharmaceutiques et Biologiques, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Hutter+S%22">Hutter S</searchLink>; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Dell'Orco+V%22">Dell'Orco V</searchLink>; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Amanzougaghene+N%22">Amanzougaghene N</searchLink>; Centre d'Immunologie et des Maladies Infectieuses (CIMI), INSERM, CNRS, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Tajeri+S%22">Tajeri S</searchLink>; Centre d'Immunologie et des Maladies Infectieuses (CIMI), INSERM, CNRS, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Franetich+JF%22">Franetich JF</searchLink>; Centre d'Immunologie et des Maladies Infectieuses (CIMI), INSERM, CNRS, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Corvaisier+S%22">Corvaisier S</searchLink>; Normandie Univ, Unicaen, CERMN, Caen, France.<br /><searchLink fieldCode="AU" term="%22Since+M%22">Since M</searchLink>; Normandie Univ, Unicaen, CERMN, Caen, France.<br /><searchLink fieldCode="AU" term="%22Malzert-Fréon+A%22">Malzert-Fréon A</searchLink>; Normandie Univ, Unicaen, CERMN, Caen, France.<br /><searchLink fieldCode="AU" term="%22Masurier+N%22">Masurier N</searchLink>; Institut des Biomolécules Max Mousseron, UMR 5247, CNRS, Université de Montpellier, ENSCM, UFR des Sciences Pharmaceutiques et Biologiques, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Lisowski+V%22">Lisowski V</searchLink>; Institut des Biomolécules Max Mousseron, UMR 5247, CNRS, Université de Montpellier, ENSCM, UFR des Sciences Pharmaceutiques et Biologiques, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Verhaeghe+P%22">Verhaeghe P</searchLink>; CHU de Nîmes, Service de pharmacie, Nimes, France; LCC-CNRS, Université de Toulouse, CNRS UPR 8241, UPS, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Mazier+D%22">Mazier D</searchLink>; Centre d'Immunologie et des Maladies Infectieuses (CIMI), INSERM, CNRS, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Azas+N%22">Azas N</searchLink>; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Vanelle+P%22">Vanelle P</searchLink>; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, Marseille, France; Service Central de la Qualité et de l'Information Pharmaceutiques, APHM, Hôpital Conception, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Primas+N%22">Primas N</searchLink>; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, Marseille, France; Service Central de la Qualité et de l'Information Pharmaceutiques, APHM, Hôpital Conception, Marseille, France. Electronic address: nicolas.primas@univ-amu.fr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220420510%22">European journal of medicinal chemistry</searchLink> [Eur J Med Chem] 2022 Nov 05; Vol. 241, pp. 114619. <i>Date of Electronic Publication: </i>2022 Jul 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Editions+Scientifiques+Elsevier%22">Editions Scientifiques Elsevier </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>0420510 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1768-3254 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202235234%22">02235234 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Med Chem <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35872545
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejmech.2022.114619
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 114619
    Titles:
      – TitleFull: Synthesis of antiplasmodial 2-aminothieno[3,2-d]pyrimidin-4(3H)-one analogues using the scaffold hopping strategy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mustière R
      – PersonEntity:
          Name:
            NameFull: Lagardère P
      – PersonEntity:
          Name:
            NameFull: Hutter S
      – PersonEntity:
          Name:
            NameFull: Dell'Orco V
      – PersonEntity:
          Name:
            NameFull: Amanzougaghene N
      – PersonEntity:
          Name:
            NameFull: Tajeri S
      – PersonEntity:
          Name:
            NameFull: Franetich JF
      – PersonEntity:
          Name:
            NameFull: Corvaisier S
      – PersonEntity:
          Name:
            NameFull: Since M
      – PersonEntity:
          Name:
            NameFull: Malzert-Fréon A
      – PersonEntity:
          Name:
            NameFull: Masurier N
      – PersonEntity:
          Name:
            NameFull: Lisowski V
      – PersonEntity:
          Name:
            NameFull: Verhaeghe P
      – PersonEntity:
          Name:
            NameFull: Mazier D
      – PersonEntity:
          Name:
            NameFull: Azas N
      – PersonEntity:
          Name:
            NameFull: Vanelle P
      – PersonEntity:
          Name:
            NameFull: Primas N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 11
              Text: 2022 Nov 05
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1768-3254
          Numbering:
            – Type: volume
              Value: 241
          Titles:
            – TitleFull: European journal of medicinal chemistry
              Type: main
ResultId 1